{"id":8520,"date":"2026-02-26T15:54:53","date_gmt":"2026-02-26T15:54:53","guid":{"rendered":"https:\/\/www.vanguardlifesciences.co.uk\/?post_type=case-study&p=8520"},"modified":"2026-02-26T16:03:26","modified_gmt":"2026-02-26T16:03:26","slug":"gene-cell-therapy-facility","status":"publish","type":"case-study","link":"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/case-study\/gene-cell-therapy-facility\/","title":{"rendered":"Centre de th\u00e9rapie cellulaire g\u00e9nique"},"content":{"rendered":"

Conception principale et construction des \u00e9l\u00e9ments sp\u00e9cialis\u00e9s<\/h3>\n
\n
\"\"<\/figure>\n<\/figure>\n

En bloc <\/a>ont \u00e9t\u00e9 choisis pour la conception compl\u00e8te et la construction sp\u00e9cialis\u00e9e de cette nouvelle installation de th\u00e9rapie cellulaire et g\u00e9nique BPF (Bonnes Pratiques de Fabrication) d'une valeur de 100 millions de livres sterling, qui sera agr\u00e9\u00e9e par la MHRA (Agence de r\u00e9glementation des m\u00e9dicaments et des produits de sant\u00e9). Cette conception comprenait tous les \u00e9l\u00e9ments en tant que ma\u00eetres d'\u0153uvre, y compris les travaux de structure et de g\u00e9nie civil.<\/p>\n

La conception a \u00e9t\u00e9 r\u00e9alis\u00e9e en 3D \u00e0 l'aide de Revit et BIM360 afin d'assurer la coordination entre les diff\u00e9rents membres de l'\u00e9quipe de conception.<\/p>\n

Les salles blanches de classe D\/C seront construites par Enbloc courant 2022 selon la m\u00e9thode PAM (modules pr\u00e9-assembl\u00e9s). Chaque salle blanche PAM disposera d'une chaufferie d\u00e9di\u00e9e, assembl\u00e9e hors site et situ\u00e9e au-dessus, afin de pr\u00e9venir tout risque de contamination crois\u00e9e.<\/p>\n

\"\"<\/figure>\n
\"\"<\/figure>\n
\"\"<\/figure>","protected":false},"excerpt":{"rendered":"

L'installation comprenait 4000 m\u00b2 de zones de cat\u00e9gorie C\/D, des zones de soutien, un stockage \u00e0 temp\u00e9rature contr\u00f4l\u00e9e, des bureaux et des entrep\u00f4ts.<\/p>","protected":false},"author":18,"featured_media":8531,"template":"","format":"standard","case-study-category":[],"case-study-topic":[],"class_list":["post-8520","case-study","type-case-study","status-publish","format-standard","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nGene Cell Therapy Facility - Vanguard Life Sciences<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/case-study\/gene-cell-therapy-facility\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gene Cell Therapy Facility - Vanguard Life Sciences\" \/>\n<meta property=\"og:description\" content=\"The facility comprised 4000m2\u00a0of Grade C\/D areas, support areas, controlled temperature storage, offices and warehousing.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/case-study\/gene-cell-therapy-facility\/\" \/>\n<meta property=\"og:site_name\" content=\"Vanguard Life Sciences\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-26T16:03:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/02\/Untitled-design-13.png\" \/>\n\t<meta property=\"og:image:width\" content=\"795\" \/>\n\t<meta property=\"og:image:height\" content=\"577\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/case-study\\\/gene-cell-therapy-facility\\\/\",\"url\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/case-study\\\/gene-cell-therapy-facility\\\/\",\"name\":\"Gene Cell Therapy Facility - Vanguard Life Sciences\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/case-study\\\/gene-cell-therapy-facility\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/case-study\\\/gene-cell-therapy-facility\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2026\\\/02\\\/Untitled-design-13.png\",\"datePublished\":\"2026-02-26T15:54:53+00:00\",\"dateModified\":\"2026-02-26T16:03:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/case-study\\\/gene-cell-therapy-facility\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/case-study\\\/gene-cell-therapy-facility\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/case-study\\\/gene-cell-therapy-facility\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2026\\\/02\\\/Untitled-design-13.png\",\"contentUrl\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2026\\\/02\\\/Untitled-design-13.png\",\"width\":795,\"height\":577},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/case-study\\\/gene-cell-therapy-facility\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gene Cell Therapy Facility\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/#website\",\"url\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/\",\"name\":\"Vanguard Life Sciences\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gene Cell Therapy Facility - Vanguard Life Sciences","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/case-study\/gene-cell-therapy-facility\/","og_locale":"fr_FR","og_type":"article","og_title":"Gene Cell Therapy Facility - Vanguard Life Sciences","og_description":"The facility comprised 4000m2\u00a0of Grade C\/D areas, support areas, controlled temperature storage, offices and warehousing.","og_url":"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/case-study\/gene-cell-therapy-facility\/","og_site_name":"Vanguard Life Sciences","article_modified_time":"2026-02-26T16:03:26+00:00","og_image":[{"width":795,"height":577,"url":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/02\/Untitled-design-13.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.vanguardlifesciences.co.uk\/case-study\/gene-cell-therapy-facility\/","url":"https:\/\/www.vanguardlifesciences.co.uk\/case-study\/gene-cell-therapy-facility\/","name":"Gene Cell Therapy Facility - Vanguard Life Sciences","isPartOf":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/case-study\/gene-cell-therapy-facility\/#primaryimage"},"image":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/case-study\/gene-cell-therapy-facility\/#primaryimage"},"thumbnailUrl":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/02\/Untitled-design-13.png","datePublished":"2026-02-26T15:54:53+00:00","dateModified":"2026-02-26T16:03:26+00:00","breadcrumb":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/case-study\/gene-cell-therapy-facility\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vanguardlifesciences.co.uk\/case-study\/gene-cell-therapy-facility\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.vanguardlifesciences.co.uk\/case-study\/gene-cell-therapy-facility\/#primaryimage","url":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/02\/Untitled-design-13.png","contentUrl":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/02\/Untitled-design-13.png","width":795,"height":577},{"@type":"BreadcrumbList","@id":"https:\/\/www.vanguardlifesciences.co.uk\/case-study\/gene-cell-therapy-facility\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.vanguardlifesciences.co.uk\/"},{"@type":"ListItem","position":2,"name":"Gene Cell Therapy Facility"}]},{"@type":"WebSite","@id":"https:\/\/www.vanguardlifesciences.co.uk\/#website","url":"https:\/\/www.vanguardlifesciences.co.uk\/","name":"Vanguard Sciences de la vie","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vanguardlifesciences.co.uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/wp-json\/wp\/v2\/case-study\/8520","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/wp-json\/wp\/v2\/case-study"}],"about":[{"href":"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/wp-json\/wp\/v2\/types\/case-study"}],"author":[{"embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/wp-json\/wp\/v2\/users\/18"}],"version-history":[{"count":0,"href":"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/wp-json\/wp\/v2\/case-study\/8520\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/wp-json\/wp\/v2\/media\/8531"}],"wp:attachment":[{"href":"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/wp-json\/wp\/v2\/media?parent=8520"}],"wp:term":[{"taxonomy":"case-study-category","embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/wp-json\/wp\/v2\/case-study-category?post=8520"},{"taxonomy":"case-study-topic","embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/fr_fr\/wp-json\/wp\/v2\/case-study-topic?post=8520"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}